ATE191850T1 - Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung - Google Patents

Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung

Info

Publication number
ATE191850T1
ATE191850T1 AT94900557T AT94900557T ATE191850T1 AT E191850 T1 ATE191850 T1 AT E191850T1 AT 94900557 T AT94900557 T AT 94900557T AT 94900557 T AT94900557 T AT 94900557T AT E191850 T1 ATE191850 T1 AT E191850T1
Authority
AT
Austria
Prior art keywords
oak bark
bark extract
ions
methods
extract
Prior art date
Application number
AT94900557T
Other languages
English (en)
Inventor
David N S Hon
R Thomas Stanley
Original Assignee
Greystone Medical Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greystone Medical Group Inc filed Critical Greystone Medical Group Inc
Application granted granted Critical
Publication of ATE191850T1 publication Critical patent/ATE191850T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Road Paving Structures (AREA)
  • Laminated Bodies (AREA)
  • Cosmetics (AREA)
AT94900557T 1992-11-06 1993-11-04 Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung ATE191850T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97307192A 1992-11-06 1992-11-06
PCT/US1993/010670 WO1994011010A2 (en) 1992-11-06 1993-11-04 Compositions of oak bark extract, related synthetic compositions, and method of using same

Publications (1)

Publication Number Publication Date
ATE191850T1 true ATE191850T1 (de) 2000-05-15

Family

ID=25520460

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94900557T ATE191850T1 (de) 1992-11-06 1993-11-04 Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung

Country Status (21)

Country Link
US (1) US6149947A (de)
EP (1) EP0668769B1 (de)
JP (1) JP3640215B2 (de)
AT (1) ATE191850T1 (de)
AU (1) AU700019B2 (de)
BR (1) BR9307401A (de)
CA (1) CA2148795C (de)
CY (1) CY2231B1 (de)
CZ (1) CZ117395A3 (de)
DE (1) DE69328438T2 (de)
DK (1) DK0668769T3 (de)
ES (1) ES2147780T3 (de)
HU (1) HUT73791A (de)
MX (1) MX9306960A (de)
NO (1) NO951740L (de)
NZ (1) NZ258019A (de)
OA (1) OA10153A (de)
PL (1) PL308770A1 (de)
PT (1) PT668769E (de)
WO (1) WO1994011010A2 (de)
ZA (1) ZA938274B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7014870B1 (en) * 1992-11-06 2006-03-21 Greystone Medical Group, Inc. Compositions of oak bark extract related synthetic compositions and method of using same
AUPN104895A0 (en) * 1995-02-10 1995-03-09 Lai, John Methods of and preparations for the treatment of ailments and disorders
US20040037898A1 (en) * 1997-10-08 2004-02-26 Hon David N.S Compositions of oak bark extract, related synthetic compositions and method of using same
RU2125460C1 (ru) * 1997-11-17 1999-01-27 Закрытое акционерное общество научно-производственная фирма "Новь" Биостимулирующее средство
US20050033251A1 (en) * 1998-12-08 2005-02-10 Quick-Med Technologies, Inc. Controlled release of biologically active substances from select substrates
US20040170703A1 (en) * 2001-11-29 2004-09-02 Greystone Medical Group, Inc. Reduction of reactive oxygen species in chronic wound management
MXPA04005219A (es) * 2001-11-29 2005-06-20 Greystone Medical Group Inc Tratamiento de heridas y composiciones empleadas.
US6667026B1 (en) 2002-03-15 2003-12-23 Pocono Falls, Inc. Allergic contact dermatitis treatment and composition therefor
US20040023937A1 (en) * 2002-05-24 2004-02-05 Greystone Medical Group, Inc. Anti-cancer formulation
CA2511440A1 (en) * 2002-12-23 2004-07-15 Greystone Medical Group, Inc. Reduction of reactive oxygen species in chronic wound management
WO2005000328A1 (en) * 2003-06-24 2005-01-06 Zanti Gianfranco Compositions based on plant ash for the treatment of skin diseases
AU2005258225A1 (en) * 2004-06-22 2006-01-05 Greystone Medical Group, Inc. Methods for treatment of wounds using time release compositions
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
WO2007089267A1 (en) 2006-02-03 2007-08-09 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US8894599B2 (en) 2007-03-15 2014-11-25 Om Kataria Uterine stimulant sticks
EP3939599A3 (de) 2007-10-15 2022-03-16 HS Pharmaceuticals, LLC Silikathaltige zusammensetzungen und verfahren zur behandlung
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
US20160184354A1 (en) 2009-01-23 2016-06-30 Jr Chem, Llc Rosacea treatments and kits for performing them
US20110200655A1 (en) * 2010-02-16 2011-08-18 Michael Darryl Black Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US8828449B2 (en) 2012-01-26 2014-09-09 Libby Robinson Wound dressing composition and method of use
US9351995B1 (en) 2011-04-29 2016-05-31 Red Oax Holdings, LLC Compositions and methods of enhancing wound healing
WO2013012968A1 (en) 2011-07-20 2013-01-24 3M Innovative Properties Company Dressing with ion-carrying composition
JP6133858B2 (ja) * 2011-07-28 2017-05-24 スリーエム イノベイティブ プロパティズ カンパニー 創傷治癒組成物及び使用方法
US9907702B2 (en) 2011-08-17 2018-03-06 3M Innovative Properties Company Monomer-grafted fibers and uses thereof
GB201402672D0 (en) 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions
WO2016123539A1 (en) 2015-01-29 2016-08-04 Wardell Mark R Wound healing compositions involving medicinal honey, mineral ions, and methylglyoxal, and methods of use
AU2019433065B2 (en) * 2019-03-04 2022-08-18 Aurealis Therapeutics AG Chloride-inducible prokaryotic expression system
IT201900018047A1 (it) * 2019-10-07 2021-04-07 Nello Vallicella Procedimento per la preparazione di una composizione topica liquida.
WO2024196897A1 (en) * 2023-03-22 2024-09-26 Courtland Imel Novel methods for increasing healing speed of human and animal wounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US55911A (en) * 1866-06-26 Improved medical compound
US37901A (en) * 1863-03-17 Improved liniment
US202246A (en) * 1878-04-09 Improvement in medical compounds
US256847A (en) * 1882-04-25 Salve
DE819127C (de) * 1949-09-28 1951-10-29 Heinz Dr Bauer Verfahren zur Herstellung eines Heilbades gegen Hautekzeme
DE812341C (de) * 1950-03-07 1951-08-27 Penicillin Ges Dauelsberg & Co Verfahren zur Herstellung eines Hautbehandlungsmittels
DE833840C (de) * 1950-06-01 1952-03-13 Dr Heinz Bauer Verfahren zur Herstellung einer Salbe gegen Hautekzeme
US3928584A (en) * 1969-06-30 1975-12-23 Us Health Education & Welfare Extracts from active tree saps for treating P388 mouse leukemia
US4059695A (en) * 1974-02-14 1977-11-22 Kanari Hirosaki Method for manufacturing a tonic composition for man and other animals
JPS60164467A (ja) * 1984-02-07 1985-08-27 Rooman Kogyo:Kk 飲料
EP0217975B1 (de) * 1985-10-08 1991-12-04 Psori-Med Ag Salzmischung zur Behandlung der Schuppenflechte (Psoriasis) und anderer Hautkrankheiten
US4847083A (en) * 1986-04-02 1989-07-11 Dermasciences, Inc. Two-step procedure for indolent wound healing and aqueous medium and topical ointment used in connection therewith
BE1000950A3 (fr) * 1987-10-05 1989-05-23 Claude Patricia Produit de beaute saliaris au sel de la mer morte et a l'argile verte de haute provence.
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
US5080900A (en) * 1990-04-17 1992-01-14 Stanley R Thomas Treatment of skin ulcers with an aqueous extract of oak bark ash

Also Published As

Publication number Publication date
HUT73791A (en) 1996-09-30
OA10153A (en) 1996-12-18
AU700019B2 (en) 1998-12-17
CY2231B1 (en) 2003-04-18
NO951740D0 (no) 1995-05-04
EP0668769B1 (de) 2000-04-19
CZ117395A3 (en) 1995-11-15
ES2147780T3 (es) 2000-10-01
DE69328438T2 (de) 2001-01-04
HU9501323D0 (en) 1996-05-28
EP0668769A1 (de) 1995-08-30
JPH08503462A (ja) 1996-04-16
BR9307401A (pt) 1999-08-24
CA2148795A1 (en) 1994-05-26
NO951740L (no) 1995-06-19
AU5550094A (en) 1994-06-08
MX9306960A (es) 1995-01-31
US6149947A (en) 2000-11-21
PL308770A1 (en) 1995-08-21
PT668769E (pt) 2000-10-31
WO1994011010A3 (en) 1994-09-15
NZ258019A (en) 1998-12-23
CA2148795C (en) 2004-08-10
JP3640215B2 (ja) 2005-04-20
WO1994011010A2 (en) 1994-05-26
ZA938274B (en) 1994-06-09
DK0668769T3 (da) 2000-10-02
DE69328438D1 (de) 2000-05-25

Similar Documents

Publication Publication Date Title
DE69328438D1 (de) Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung
DE3779149D1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ES2033434T3 (es) Composicion cosmetica.
WO1994011010B1 (en) Compositions of oak bark extract, related synthetic compositions, and method of using same
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
ATE233558T1 (de) Verwendung von strontiumsälze zur behandlung von arthrose
KR900700128A (ko) 외상 치료법
DE59601880D1 (de) Verfahren zur herstellung hydrophiler oder teilweise hydrophiler, anorganischer aerogele
AU6998787A (en) Transglutaminase inhibitors
ATE225340T1 (de) Einschlusskomplexe von taxol oder taxotere oder taxus-extrakten und cyclodextrinen, ihre herstellung und ihre verwendung
ATE232394T1 (de) Verwendung von modifiziertem c-reaktiven protein zur herstellung eines medikaments zur behandlung von krebs
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ATE179594T1 (de) Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
DE69026511D1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ATE42466T1 (de) Verwendung von saccharomyces hefen zur herstellung eines medikaments zur verhuetung oder behandlung von pseudomembrankolitis.
DE59900286D1 (de) Verwendung von sphingosin-1-phosphat, sphingosin-1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten
DE69232852D1 (de) Verwendung von topotecan in der behandlung von nichtkleinzelligen lungenkarzinomen
NZ220495A (en) A2a cyclopeptan-2-ones carrier containing methotrexate compositions
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
ATE107166T1 (de) Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration.
IT1199960B (it) Agenti stimolanti la crescita dei capelli e loro impiego
ATE77952T1 (de) Verwendung von 1,4-dihydropyridinderivaten.
DE69117566D1 (de) Verwendung von Isomonoolen zur Behandlung und Prophylaxe von Krebserkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee